Business Wire

  1. SurModics Acquires Drug Delivery Assets Of PR Pharmaceuticals 11/4/2008
    SurModics, Inc. , a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that it has acquired a portfolio of intellectual property and collaborative drug delivery projects from PR Pharmaceuticals, Inc., a drug delivery company specializing in injectable, biodegradable sustained release formulations.
  2. BIO-Europe 2008 VIPs Share Insights On Keeping Innovation Moving In Turbulent Financial Economy 11/3/2008
    The stage is set for BIO-Europe 2008, November 17-19 in Mannheim/Heidelberg, Germany, to be the largest and most productive stand-alone partnering event on record.
  3. Actavis Opens Research And Development Labs In Florida 11/3/2008
    Actavis South Atlantic (ASA), a United States division of the international generic pharmaceutical company Actavis, has opened new analytical and R&D laboratories to expand the Company's research and development efforts for controlled release (CR) and other technically difficult generic pharmaceutical products.
  4. Reframing The Value Proposition Of Pharmaceutical Sales 10/30/2008
    Blue Spoon Consulting Group, LLC, recently published a framework for pharmaceutical companies to develop a new value proposition for sales into medical group practices.
  5. IMS Health Forecasts 4.5% To 5.5% Growth For Global Pharmaceutical Market in 2009, Exceeding $820 Billion 10/29/2008
    The global pharmaceutical market is expected to grow 4.5 - 5.5 percent next year, a pace similar to 2008, according to the IMS Global Pharmaceutical and Therapy Forecast released today by IMS Health.
  6. FDA Awards NIPTE $1.19 Million Contract To Develop Quality By Design (QbD) Guidance Elements 10/29/2008
    The U.S. Food and Drug Administration (FDA) has awarded the National Institute for Pharmaceutical Technology and Education (NIPTE) a contract to develop Quality by Design guidance on design space specifications.
  7. AMRI Expands Manufacturing Capabilities In India; Adds Non-GMP Plant Capacity 10/29/2008
    AMRI today announced the expansion of multipurpose pilot plant facilities in Aurangabad, India providing non-GMP manufacturing services up to a 1,000 liter scale.
  8. URCH Publishing Releases Market Report On China's Pharmaceutical Regulations 10/29/2008
    URCH Publishing provides comprehensive insight into China's 2007 revised pharmaceutical regulations.
  9. Synexus® Is Planning To Double Clinical Trial Capacity In South Africa 10/28/2008
    Synexus® is planning to more than double its clinical trial capacity in South Africa through the expansion of its Pretoria facilities and by opening two purposed designed sites, one in Mamelodi and one in Soshanguwe.
  10. Eidetics Launches Groundbreaking Data Visualization Service To Enable Pharma To Make Better Drug Development Decisions 10/28/2008
    Eidetics, a leading global healthcare market research firm and division of Quintiles Consulting, announced the commercial launch of their proprietary service application, Provenance. The new interactive tool provides pharmaceutical brand teams and clinical researchers with a panoramic view of complex data, utilizing advanced data mining techniques and Bayesian networks.